Fulcrum Therapeutics FULC
NASDAQ FULC
$3.85 +0.01 (+0.26%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fulcrum Therapeutics (FULC) FCF Margin (QoQ) (2020 - 2023)

Analysis

Fulcrum Therapeutics (FULC) FCF Margin (QoQ) (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Fulcrum Therapeutics 293.24 Mn 293.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 35,886.00
Sep 30, 2023 -64,239.00
Jun 30, 2023 584,879.00
Mar 31, 2023 -534,062.00
Dec 31, 2022 -51,145.00
Sep 30, 2022 -88,862.00
Jun 30, 2022 -60,666.00
Mar 31, 2022 -44,312.00
Dec 31, 2021 2,243.00
Sep 30, 2021 -4,517.00
Jun 30, 2021 -7,539.00
Mar 31, 2021 13,614.00
Dec 31, 2020 -23,167.00
Sep 30, 2020 46,779.00
Jun 30, 2020 138,625.00